Bracanat 150mg Tablet

Product Introduction

Bracanat 150mg Tablet is a medicinal product primarily utilized in the field of oncology, specifically designed to treat various forms of cancer. The active ingredient in Bracanat 150mg Tablet is a potent chemotherapeutic agent known for its efficacy in targeting and inhibiting the proliferation of cancerous cells. Bracanat belongs to a class of medications known as protein kinase inhibitors, which function by blocking the action of enzymes essential for the growth and survival of cancer cells. By interfering with these enzymes, Bracanat effectively hampers the ability of cancer cells to multiply and spread, thereby aiding in the control and reduction of tumor size.

Manufactured under stringent pharmaceutical standards, Bracanat 150mg Tablet is formulated to ensure maximum therapeutic benefit while maintaining an acceptable safety profile. The medication is typically prescribed by oncologists and is often part of a broader treatment regimen that may include other chemotherapeutic agents, radiation therapy, or surgical interventions. The tablet form of Bracanat allows for convenient oral administration, making it a preferred choice for many patients undergoing long-term cancer treatment.

Uses of Bracanat 150mg Tablet

Bracanat 150mg Tablet is primarily indicated for the treatment of various types of cancers, including but not limited to:

• Breast Cancer: Particularly in cases where the cancer is advanced or has metastasized. Bracanat is often used when other treatments have not been effective or when the cancer is known to have specific genetic mutations that Bracanat targets.
• Lung Cancer: Specifically non-small cell lung cancer (NSCLC) that exhibits certain genetic characteristics making it susceptible to treatment with Bracanat.
• Gastrointestinal Stromal Tumors (GIST): Bracanat is utilized in cases where tumors are unresectable or have metastasized, especially if the tumors are resistant to other forms of chemotherapy.

In addition to these primary uses, ongoing research and clinical trials are exploring the potential of Bracanat 150mg Tablet in treating other types of cancer and in combination with newer therapies to enhance its efficacy and broaden its application.

Benefits of Bracanat 150mg Tablet

The benefits of Bracanat 150mg Tablet are multi-faceted and significant, particularly for patients battling advanced or resistant forms of cancer. Key benefits include:

• Targeted Therapy: Unlike traditional chemotherapy, which can affect both healthy and cancerous cells, Bracanat offers a more targeted approach, aiming specifically at cancer cells. This targeted action helps to minimize collateral damage to healthy tissues, thereby reducing side effects.
• Improved Survival Rates: Clinical studies have shown that patients treated with Bracanat often experience improved survival rates, particularly in cancers with specific genetic mutations targeted by the drug.
• Convenience: The oral administration of Bracanat 150mg Tablet provides a convenient alternative to intravenous chemotherapy, allowing patients to maintain a greater degree of normalcy in their daily lives while undergoing treatment.
• Reduced Tumor Progression: Bracanat has demonstrated efficacy in slowing down the progression of tumors, thereby improving the quality of life for patients and providing them with more time to explore additional treatment options.

Side Effects of Bracanat 150mg Tablet

While Bracanat 150mg Tablet offers significant therapeutic benefits, it is not without its side effects. The extent and severity of these side effects can vary based on individual patient factors, including overall health, the specific type of cancer being treated, and concurrent treatments. Common side effects include:

• Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain are frequently reported. These symptoms can often be managed with supportive medications and dietary adjustments.
• Fatigue: Many patients experience fatigue, which can be debilitating and affect daily activities. Adequate rest and supportive care are essential in managing this side effect.
• Skin Reactions: Rash, dryness, and other skin-related issues are common. Topical treatments and good skincare practices can help alleviate these symptoms.
• Liver Function Alterations: Bracanat can affect liver enzymes, necessitating regular monitoring of liver function tests to ensure no significant damage occurs.
• Hematologic Changes: Alterations in blood counts, including reduced white blood cells, red blood cells, and platelets, can occur, increasing the risk of infections, anemia, and bleeding disorders. Regular blood tests are essential to monitor these changes.
• Cardiovascular Effects: Though less common, some patients may experience cardiovascular side effects such as hypertension or heart rhythm disturbances. Regular cardiovascular monitoring is recommended for patients at risk.

References